Mikael Sodergren MBChB, DIC, PhD, FRCS is a Senior Clinical Lecturer at Imperial College London and Consultant Hepatobiliary & Pancreatic Surgeon at Imperial College Healthcare NHS Trust.
His clinical interests include complex pancreas, liver & gallbladder cancer surgery as well as laparoscopic & robotic approaches. He spearheaded the team that pioneered and carried out the first cases of natural orifice translumenal endoscopic surgery (NOTES) in the UK.
His research portfolio is based on novel technological innovation & therapeutics with the following major themes:
1) Immunomodulatory Cancer Therapies with a focus on radiofrequency ablation, saRNA and aptamer technologies applied to hepatocellular carcinoma and pancreatic ductal adenocarcinoma
2) He leads the Medical Cannabis Research Group - a research programme which evaluates and develops novel therapies targeting the endocannabinoid system through a framework of in vitro, in vivo and clinical translational activities
4) Medical Eye-Tracking - investigating the innovative application of this technology to improve outcomes in patients undergoing surgery and other medical interventions
et al., 2022, Visual gaze patterns in trainee endoscopists - a novel assessment tool, Scandinavian Journal of Gastroenterology, ISSN:0036-5521
et al., 2022, A systematic review of robotic surgery: From supervised paradigms to fully autonomous robotic approaches, International Journal of Medical Robotics and Computer Assisted Surgery, Vol:18, ISSN:1478-5951, Pages:1-11
et al., 2022, Quality of life after pancreatic surgery - A systematic review., Hpb (oxford)
et al., 2022, An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry., Cannabis Cannabinoid Res
et al., 2022, UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder, Expert Review of Clinical Pharmacology, ISSN:1751-2433